Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics: Executive Summary

Aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone are atypical antipsychotics approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia and bipolar disorder.